Biopharmaceutical Research Co — Form D
Biopharmaceutical Research Co of CASTROVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-09. The offering totals $676K, of which $676K was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-08-09
- Form: D
- Accession: 0001826834-23-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $676K
- Amount sold: $676K
- Investors: 1
- Date of first sale: 2023-08-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-489227
Issuer
- Name: Biopharmaceutical Research Co
- CIK: 0001826834
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 11045 COMMERCIAL PARKWAY, CASTROVILLE, CA, 95012
- Phone: 831-632-0913
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| George Bennett Hodgin | Director | Castroville, CA |
| Osagie Bennett Imasogie | Director | Castroville, CA |
| Charles Bennett Schumacher | Director | Castroville, CA |
| George Bennett Hodgin | Executive Officer | Castroville, CA |
| David Bennett Weinmann | Executive Officer | Castroville, CA |
| Edward Howard Goodwin | Director | Castroville, CA |
| Charles Schumacher | Director | Castroville, CA |
| George Hodgin | Director | Castroville, CA |
| George Hodgin | Executive Officer | Castroville, CA |
Other filings by this issuer (6)
More